BRAF V600E mutations are not an oncogenic driver of solitary xanthogranuloma and reticulohistiocytoma: Testing may be useful in screening for Erdheim-Chester disease.
Exp Mol Pathol
; 111: 104320, 2019 12.
Article
in En
| MEDLINE
| ID: mdl-31639332
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers, Tumor
/
Erdheim-Chester Disease
/
Proto-Oncogene Proteins B-raf
/
Mutation
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Exp Mol Pathol
Year:
2019
Document type:
Article
Affiliation country:
United States
Country of publication:
Netherlands